Who is sponsoring NCT04965168?

NCT04965168 is sponsored by Minia University.

What drugs are being tested in NCT04965168?

Interventions in NCT04965168: phacoemulsification of the lens.

What condition does NCT04965168 study?

NCT04965168 studies Pseudoexfoliation.

Is NCT04965168 still recruiting?

NCT04965168 is currently completed. Last updated 12 November 2021.

Last reviewed 2021-11-12 · How we verify

NCT04965168

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Corneal Endothelium Evaluation After Phacoemulsification in Diabetec and Non-diabetic Patients With Pseudoexfoliation

Completed NA Last updated 12 November 2021

What this trial tests

NA trial testing phacoemulsification of the lens in Pseudoexfoliation in 61 participants. Completed in 16 October 2021.

Timeline

1 December 2020

Primary endpoint
12 October 2021

16 October 2021

Quick facts

Lead sponsor	Minia University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	61
Start date	1 December 2020
Primary completion	12 October 2021
Estimated completion	16 October 2021
Sites	1 location across Egypt

Drugs / interventions tested

phacoemulsification of the lens

Conditions studied

Pseudoexfoliation — all drugs for Pseudoexfoliation →

Sponsor

Minia University

Who can join

Adults 50 to 70, any sex, with Pseudoexfoliation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Our study is a comparative study, that was conducted to evaluate the corneal endothelial cells changes and central corneal thickness after uncomplicated phacoemulsification and intra ocular lens (IOL) implantation in normal controls, in non-diabetic and diabetic patients with PEX, and in patients with PEX only using specular microscopy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Evaluation of the corneal thickness and endothelial changes following uncomplicated phacoemulsification in diabetic and non-diabetic patients with pseudo-exfoliation syndrome by specular microscopy.
Mahmoud MSE, Omar IAN, AttaAllah HR. · · 2023 · cited 1× · PMID 37721703 · DOI 10.1007/s10792-023-02877-x

Verify or expand the search:

Other Minia University trials

Trials by the same sponsor.

NCT07525687 — Temporary Uterine Tourniquet Application Versus Local Myometrial Epinephrine Injection During Laparoscopic Myomectomy · NA · not yet recruiting
NCT07525674 — Vacuum Sealing Drainage (VSD) in Promoting Wound Healing and Reducing Complications in Post-Infected Obstetric and Gynec · NA · not yet recruiting
NCT07529587 — Laparoscopic Umbilico-uterine Trunk Clipping Approach in the Management of Enhanced Myometrial Vascularity · NA · not yet recruiting
NCT07500558 — Ultrasound Guided Infratemporal Sphenopalatine Ganglion Supravoltage Versus Standard Voltage Pulsed Radiofrequency for P · NA · not yet recruiting
NCT07428057 — Postoperative Hypocalcemia After Thyroidectomy · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04965168 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Minia University
Last refreshed: 12 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04965168.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing